Viewing Study NCT01065766


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-02-02 @ 6:58 PM
Study NCT ID: NCT01065766
Status: COMPLETED
Last Update Posted: 2015-03-06
First Post: 2010-02-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus View
None Non-Insulin-Dependent View